Learn More
Medchemexpress LLC Ensitrelvir | 2647530-73-0 | 99.6% | C22H17ClF3N9O2 | 25 MG

Supplier: Medchemexpress LLC 25MGHY143216
Ensitrelvir (S-217622) is the first orally active non-covalent, non-peptidic SARS-CoV-2 3CL protease inhibitor (IC50=13 nM). It is for research use only.
- Orally active non-covalent, non-peptidic SARS-CoV-2 3CL protease inhibitor.
- Inhibits intrapulmonary replication of SARS-CoV-2 in mice dose-dependently.
- Shows EC50 values of approximately 0.4 μM for both wild-type virus and Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 in a cytopathic effect (cpe)-inhibition assay in VeroE6/TMPRSS2 cells.
- EC50 values for SARS-CoV and MERS-CoV were 0.21 and 1.4 μM, respectively.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.